What is the Aroa Biosurgery (ASX: ARX) share price?
The ARX share price is $0.605, down 3.97% for the day, based on the latest available ASX market data.
What is Aroa Biosurgery's market capitalisation?
Aroa Biosurgery has a market capitalisation of $209.0M, making it the 649th-largest security listed on the ASX.
Does Aroa Biosurgery pay a dividend?
ARX does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
What is ARX's P/E ratio?
Aroa Biosurgery trades on a trailing price-to-earnings (P/E) ratio of 9.96, based on its current share price and most recent reported earnings.
Is Aroa Biosurgery profitable?
Yes. In its most recent reported period (ending 31 Mar 2026), ARX reported revenue of $50.8M and a net profit of $5.2M.
How many ARX shares are on issue?
Aroa Biosurgery has approximately 345,472,395 shares on issue, based on its market capitalisation of $209.0M and current share price.
What sector is Aroa Biosurgery in?
Aroa Biosurgery is classified in the Healthcare sector, within the Medical - Devices industry on the ASX.
When did Aroa Biosurgery list on the ASX?
Aroa Biosurgery listed on the Australian Securities Exchange on 24 July 2020.
